Red Cross Hit With Antitrust Suit For Platelet Treatment Tying

By Kelly Lienhard · February 15, 2023, 6:07 PM EST

The American Red Cross has been accused by a biotech company of launching an illegal campaign to "smother" competition in the platelet bacteria mitigation market by tying its platelet sales to...

To view the full article, register now.

Documents

Case Information

Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

1:23-cv-10335

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

February 14, 2023